This Sounding Board announces a new @fda policy that the default requirement for FDA approvals will be one robust pivotal trial plus confirmatory evidence, rather than two trials. Learn more Redispersibility of Paper Under Low Agitation and How It Deteriorates over Time When should a paper be retracted? A tale from the obesity literature Retraction Watch The Dihexa story Most hyped brain peptide of the decade. "10,000,000x more potent than BDNF." Based on one paper retracted in 2021. Swipe through all 7 slides. For research purposes only.